Literature DB >> 29857970

Nivolumab-induced Limbic Encephalitis with Anti-Hu Antibody in a Patient With Advanced Pleomorphic Carcinoma of the Lung.

Hiroki Matsuoka1, Hideharu Kimura2, Hayato Koba1, Yuichi Tambo3, Noriyuki Ohkura3, Johsuke Hara3, Takashi Sone4, Kazuo Kasahara3.   

Abstract

Entities:  

Keywords:  Anti-Hu antibody; Limbic encephalitis; Nivolumab

Mesh:

Substances:

Year:  2018        PMID: 29857970     DOI: 10.1016/j.cllc.2018.04.009

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN: 1525-7304            Impact factor:   4.785


× No keyword cloud information.
  13 in total

1.  IFN-γ is a therapeutic target in paraneoplastic cerebellar degeneration.

Authors:  Lidia Yshii; Béatrice Pignolet; Emilie Mauré; Mandy Pierau; Monika Brunner-Weinzierl; Oliver Hartley; Jan Bauer; Roland Liblau
Journal:  JCI Insight       Date:  2019-04-04

Review 2.  Paraneoplastic neurological syndrome: growing spectrum and relevance.

Authors:  Valakunja Harikrishna Ganaraja; Mohamed Rezk; Divyanshu Dubey
Journal:  Neurol Sci       Date:  2022-04-23       Impact factor: 3.307

3.  How to diagnose and manage neurological toxicities of immune checkpoint inhibitors: an update.

Authors:  Alberto Vogrig; Sergio Muñiz-Castrillo; Antonio Farina; Jérôme Honnorat; Bastien Joubert
Journal:  J Neurol       Date:  2021-10-27       Impact factor: 4.849

Review 4.  Neurotoxicity and safety of the rechallenge of immune checkpoint inhibitors: a growing issue in neuro-oncology practice.

Authors:  M Villagrán-García; R Velasco
Journal:  Neurol Sci       Date:  2022-02-17       Impact factor: 3.830

Review 5.  Subacute sensory neuronopathy associated with Merkel cell carcinoma with unknown primary: a case report with literature review.

Authors:  Riccardo Milani; Miryam Cannizzaro; Gianluigi Arrigoni; Federica Filipello; Federica Cerri; Massimo Filippi
Journal:  J Neurol       Date:  2022-04-16       Impact factor: 6.682

6.  Paraneoplastic Sensory Polyneuropathy Related to Anti-PD-L1-including Anticancer Treatment in a Patient with Lung Cancer.

Authors:  Toshiki Morimoto; Takeshi Orihashi; Kei Yamasaki; Masahiro Tahara; Kaori Kato; Kazuhiro Yatera
Journal:  Intern Med       Date:  2020-12-15       Impact factor: 1.271

7.  Anti-Hu-associated paraneoplastic syndromes triggered by immune-checkpoint inhibitor treatment.

Authors:  Neus Mongay-Ochoa; Alberto Vogrig; Sergio Muñiz-Castrillo; Jerome Honnorat
Journal:  J Neurol       Date:  2020-05-25       Impact factor: 4.849

8.  Clinical Characterization of Definite Autoimmune Limbic Encephalitis: A 30-case Series.

Authors:  Yuri Shojima; Kenya Nishioka; Masao Watanabe; Takayuki Jo; Keiko Tanaka; Hiroshi Takashima; Kazuyuki Noda; Yasuyuki Okuma; Takao Urabe; Kazumasa Yokoyama; Nobutaka Hattori
Journal:  Intern Med       Date:  2019-08-21       Impact factor: 1.271

Review 9.  Central Nervous System Demyelination Associated With Immune Checkpoint Inhibitors: Review of the Literature.

Authors:  Marcos C B Oliveira; Marcelo H de Brito; Mateus M Simabukuro
Journal:  Front Neurol       Date:  2020-12-11       Impact factor: 4.003

Review 10.  Paraneoplastic neurological syndrome: an evolving story.

Authors:  Jiraporn Jitprapaikulsan; Pritikanta Paul; Smathorn Thakolwiboon; Shivam Om Mittal; Sean J Pittock; Divyanshu Dubey
Journal:  Neurooncol Pract       Date:  2021-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.